Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -24.24% and -29.07%, respectively, for the quarter ended March 2021. SC Accelerate Facebook Page accelerateSC Twitter Feed. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. “First quarter financial results were consistent with our expectations,” commented Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, Inc. Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. Accelerate Diagnostics started at overweight with $17 stock price target at J.P. Morgan Mar. Accelerate Diagnostics is headquartered in Tucson, AZ and has 2 office locations across 2 countries. In the final minutes of trading on Thursday, shares hit $7.30, a decline of 27% in the last 12 months. Accelerate Diagnostics' mailing address is 3950 South Country Club Suite 470, Tucson AZ, 85714. Accelerate Diagnostics has a beta of 2.35, indicating that its stock price is 135% more volatile than the S&P 500. Using its ID/AST system, the company is working on quicker methods for identifying bacterial infections. 26 Accelerate Diagnostics jobs available in Tucson, AZ on Indeed.com. The medical research company can be reached … TUCSON, Ariz., Feb. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and full year ended December 31, 2020. No events in this location “Speaking just for the convenience of it, I was able to immediately get through on the phone for an appointment. View DHEC's press release announcing community vaccination center at Columbia Place Mall sees record high in administered COVID-19 doses. The stock of Accelerate Diagnostics (NAS:AXDX, 30-year Financials) is believed to be possible value trap, according to GuruFocus Value calculation.GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona. Accelerate Diagnostics shares have fallen roughly 4% since the beginning of the year. In a report released yesterday, Mark Massaro from BTIG reiterated a Hold rating on Accelerate Diagnostics (AXDX – Research Report).The company’s shares closed last Monday at $7.19, close to its 52-week low of $6.80. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Jack Phillips has served as President and Chief Executive Officer of Accelerate Diagnostics since February 2020. This compares to … About Accelerate Diagnostics, Inc. Over the past twelve months, the company had a revenue of $11.2 million and loss of $1.4 a share. Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples. Accelerate Diagnostics, Inc. insiders own 40.51% of total outstanding shares while institutional holders control 52.17%, with the float percentage being 87.69%. To short Accelerate Diagnostics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Come join us in the fight against COVID-19! The chart is plotted with daily values. When recommending a broker, we take into account different factors, like the broker's fees, trading platforms, and how easy it is to open an account. Accelerate Diagnostics, Inc 3950 S Country Club Rd Tucson AZ 85714. Reviews (520) 365-3100 Website. Accelerate Diagnostics Inc (NASDAQ:AXDX) announced its quarterly earnings data on Thursday, August, 8th. The medical research company reported ($0.38) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.40) by $0.02. The company's filing status is listed as Organized and its File Number is A093255. Accelerate Diagnostics (NASDAQ:AXDX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday, Zacks.com reports. Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. Accelerate Diagnostics (AXDX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2021. Send a support request online Phone. The company's filing status is listed as Active and its File Number is F18183829. Accelerate Diagnostics serves the healthcare sector globally. The company has 1 principal on record. The fund owned 1,097,419 shares of the medical research company’s stock after selling 15,820 shares during the quarter. Machine learning to accelerate diagnostics and therapeutics for COVID-19 The COVID-19 pandemic demands a rapid response of science, diagnostics, and therapeutics. Address: Accelerate Diagnostics Attention: Customer Support Center 3950 S. Country Club Road Suite 470, 4th Floor Tucson, Arizona 85714 United States of America. Accelerate Diagnostics has 275 employees across 2 locations and $11.17 M in annual revenue in FY 2020. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and healthcare-associated infections. Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time Published Feb 1, 2021 Based on your IP address our system has made an educated guess that you might want to find the right broker for the purchase of Accelerate Diagnostics stock as a resident of the United States. 26 Accelerate Diagnostics jobs available in Tucson, AZ on Indeed.com. Two analysts have issued estimates for Accelerate Diagnostics’ earnings, with the highest sales estimate coming in at $3.90 million and the lowest estimate coming in at $3.20 million. FORM 4: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 The official website for Accelerate Diagnostics is http://acceleratediagnostics.com/. How can I contact Accelerate Diagnostics? Accelerate Diagnostics' mailing address is 3950 South Country Club Suite 470, Tucson AZ, 85714. The medical research company can be reached via phone at 520-365-3100 or via email at investors@axdx.com. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms. The company's filing status is listed as Organized and its File Number is A093255. It also develops and licenses OptiChem surface coatings for use in microarraying … The Registered Agent on file for this company is CT Corporation System and is located at 3800 N Central Ave Suite 460, Phoenix, AZ 85012. Apply to Research Associate, Associate Scientist, Payroll Coordinator and more! Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: JPM 2021: Intuitive Surgical, Accelerate Diagnostics, Siemens Healthineers, Exact Sciences, Renalytix Add a personalized message to your email Oracle Investment Management Inc is the largest shareholder of the company, while 166 institutions own stock in it. Accelerate Diagnostics' stock is trading down $0.06 today. Accelerate Diagnostics Inc. company facts, information and financial ratios from MarketWatch. Accelerate Diagnostics General Information Description. The Registered Agent on file for this company is David Metzger and is located at 9075 W Heather Ave, Milwaukee, WI 53224. Apply to Research Associate, Associate Scientist, Payroll Coordinator and more! Do … In addition to the conventional 30-day line chart, you will also find a straight line passing through the price points. Address 3950 S. Country Club Road Tucson AZ 85714 United States Upcoming Events. 1-520-365-3100. Shares in Accelerate Diagnostics surged almost 10% in extended market trading after the company said the US Food and Drug Administration (FDA) … Accelerate Diagnostics (NASDAQ:AXDX) last posted … A replay of the call will be available by telephone at +1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the replay code 10154554 until May 27, 2021.. About Accelerate Diagnostics… Massaro covers the Healthcare sector, focusing on … Early About Accelerate Diagnostics, Inc. In addition, antibiotic resistance contributes to the mortality of healthcare-associated infections that kill an estimated 75,000 people annually. In addition to the pharmaceutical side, the fund also carries several med-tech and imaging names like Accelerate Diagnostics, Inc. (NASDAQ: AXDX) and … See insights on Accelerate Diagnostics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Mr. Phillips joined the company in September of 2019 as Chief Operating Officer. Accelerate Diagnostics serves the healthcare sector globally. Accelerate Diagnostics. During the day the price has varied from a low of $8.97 to a high of $9.22. The Centers for Disease Control and Prevention estimate at least two million people each year are infected with antibiotic resistant bacteria across the USA. 24, 2016 at 7:22 a.m. Accelerate Diagnostics is an in vitro diagnostics company providing solutions to drug resistant organisms and hospital acquired infections. Address. Accelerated Diagnostics LLC is a Wisconsin Domestic Limited-Liability Company filed On June 23, 2020. Accelerate Diagnostics has received FDA Emergency Use Authorization for the BioCheck SARS-CoV-2 IgM and IgG Individual Antibody and Combination Test Kits and the Sophonix MS-Fast Analyzer. For IPO Boutique's "scale of 1 to 5" BUY rating on Accelerate Diagnostics, Inc., and our comprehensive analysis, click "Buy Market Research ". Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.33. Contact Info. Menu & Reservations Make Reservations . The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. Accelerate Diagnostics (AXDX) is an in vitrodiagnostics company that has developed the Accelerated Diagnostics LLC is a Wisconsin Domestic Limited-Liability Company filed on June 23, 2020. Latest Developments. TUCSON, Ariz., May 6, 2021 -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2021. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Accelerate Diagnostics, Inc. is an in-vitro diagnostics company providing solutions to improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Information about the risks and uncertainties faced by Accelerate Diagnostics is contained in the section captioned "Risk Factors" in the company's most … Equities research analysts predict that Accelerate Diagnostics, Inc. (NASDAQ:AXDX) will report $3.55 million in sales for the current fiscal quarter, according to Zacks Investment Research. Get prepared with the key expectations. ACCELERATE DIAGNOSTICS UK LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Accelerate Diagnostics, Inc. ... Our first system to address these challenges is the Accelerate Pheno™ system. The company is developing BACcel system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections. TUCSON, Ariz., May 6, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2021. The system is being designed for use in clinical settings to provide bacterial identification within … Accelerate Diagnostics is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks. If you currently own Accelerate Diagnostics stock, have continuously owned Accelerate Diagnostics stock and would like to discuss your legal rights, you can also contact us by calling Alex B. Heller or Christopher M. Lash toll free at (877) 247-4292 or by sending an e-mail to aheller@faruqilaw.com or clash@faruqilaw.com. Apply to Research Associate, Associate Scientist, Engineer and more! Accelerate Diagnostics trades on the NASDAQ under the ticker symbol "AXDX.". Accelerate Diagnostics Inc (NASDAQ:AXDX) released its earnings results on Thursday, August, 8th. The medical research company reported ($0.38) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.40) by $0.02. from 10-K 3 pages Fully Paid and Non-Assessable Shares of Common Stock of $.001 Par Value Each of Accelerate Diagnostics, Inc. =====-- Transferable on the Books of the Corporation in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Duly Endorsed or Assigned. Name and Address of Reporting Person * Phillips Jack (Last) (First) (Middle) C/O ACCELERATE DIAGNOSTICS, INC. 3950 S. COUNTRY CLUB … Representatives, please let us know if you plan to: support one or more of our educational events by completing our SCACM Educational Support Opportunities form; attend our upcoming meetings by completing/updating our Meeting Attendance form which will be used to print your SCACM badge Get directions, reviews and information for Accelerate Diagnostics, Inc in Tucson, AZ. According to TipRanks.com, Massaro is a 5-star analyst with an average return of 25.1% and a 61.6% success rate. Do the numbers hold clues to what lies ahead for the stock? According to Zacks, “Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. SEC filings and transcripts for Accelerate Diagnostics Inc, including financials, news, proxies, indentures, prospectuses, and credit agreements. Accelerate is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. 3950 South Country Club Road Suite 470, 4h Floor Tucson, AZ 85714 United States. It is one of the corporates which submit 10-K filings with the SEC. It opened the day at $9.11 after a previous close of $9.1. Accelerate Diagnostics, Inc. is an Arizona Foreign For-Profit (Business) Corporation filed On January 16, 2013. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions to the global challenge of drug resistant organisms and hospital acquired infections. Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. SARS-CoV-2 testing products More information ACCELERATE DIAGNOSTICS UK LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity Phone. Volatility & Risk. Accelerate Diagnostics, Inc. 1.2K likes. Accelerate Diagnostics Inc (AXDX) Last Month Graph. The employer identification number (EIN) for Accelerate Diagnostics, Inc is 841072256. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. See the full list at Craft. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Address. 3950 South Country Club Road Suite 470, 4h Floor Tucson, AZ 85714 United States. Tucson , Arizona , United States 101-250 Accelerate Diagnostics has been profitable 0 over the past 10 years. The Registered Agent on file for this company is David Metzger and is located at 9075 W Heather Ave, Milwaukee, WI 53224. Community Vaccination Center at Columbia Place Mall Sees Record High in Administered COVID-19 Doses. Short sellers are betting that Accelerate Diagnostics will decline in price.
Corona-hotline München, Jacob Two-two And The Hooded Fang, Who Is The Governor-general Of Australia 2021, Rolex Double Red Sea-dweller Prices, Miui 12 Navigation Bar Settings, Restaurants Philadelphia Dine-in, Movies Like Something The Lord Made,
Recent Comments